R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal ArticleDOI
Improvement of albuminuria after renal denervation
Christian Ott,Felix Mahfoud,Axel Schmid,Tilmann Ditting,Roland Veelken,Sebastian Ewen,Christian Ukena,Michael Uder,Michael Böhm,Roland E. Schmieder +9 more
TL;DR: Following RDN, the magnitude of albuminuria as well as the prevalence of micro- and macroalbuminuria decreased in treatment-resistant hypertensive patients, suggesting a reduction of renal and cardiovascular risk in these patients.
Journal ArticleDOI
Cost of poor adherence to anti-hypertensive therapy in five European countries
FS Mennini,FS Mennini,Andrea Marcellusi,Andrea Marcellusi,J.-M. Graf von der Schulenburg,Alastair Gray,Pierre Levy,Paolo Sciattella,M. Soro,Gianandrea Staffiero,Jan Zeidler,Aldo P. Maggioni,Roland E. Schmieder +12 more
TL;DR: In this article, a probabilistic prevalence-based decision tree model was developed to estimate the direct costs of cardiovascular disease related to hypertension in five European countries (Italy, Germany, France, Spain and England).
Journal ArticleDOI
Wall-to-Lumen Ratio of Retinal Arterioles as a Tool to Assess Vascular Changes
Martin Ritt,Roland E. Schmieder +1 more
TL;DR: A new approach focuses on retinal arteriolar structural parameters by using scanning laser Doppler flowmetry with automatic full-field perfusion imaging analyses (AFFPIAs) and explains the improved power of measuring retinal vascular changes, and discusses the recent findings using this tool.
Journal ArticleDOI
1166 A/C Polymorphism of the Angiotensin II Type 1 Receptor Gene and the Response to Short-Term Infusion of Angiotensin II
Karl F. Hilgers,Matthias R.W. Langenfeld,Markus P. Schlaich,Roland Veelken,Roland E. Schmieder +4 more
TL;DR: It is concluded that the 1166 A/C polymorphism of the Ang II type 1 receptor does not lead to a greater blood-pressure, aldosterone, or renal vascular response to infused Ang II in young, male, white subjects.
Journal ArticleDOI
Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review
Márcio Galindo Kiuchi,Murray D. Esler,Gregory D. Fink,John W. Osborn,Christopher T. Banek,Michael Böhm,Kate M. Denton,Gerald F. DiBona,Thomas H. Everett,Guido Grassi,Richard E. Katholi,Mark M. Knuepfer,Ulla C. Kopp,David J. Lefer,Thomas E. Lohmeier,Clive N. May,Felix Mahfoud,Julian F. R. Paton,Roland E. Schmieder,Peter Ricci Pellegrino,Yehonatan Sharabi,Markus P. Schlaich +21 more
TL;DR: Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.